-- Genzyme completes tender offer for AnorMED
-- 
-- Tue Nov 7, 2006 5:48pm EST
-- http://www.reuters.com/article/2006/11/07/us-genzyme-idUSWEN933520061107

 

 LOS ANGELES  (Reuters) - Genzyme Corp. GENZ.0 said on Tuesday it has completed its acquisition of AnorMED Inc. AOM.TO for $13.50 per share, or $584 million. 

 Genzyme said it will apply to have AnorMED delisted from Nasdaq and the Toronto Stock Exchange so that the stock will cease trading.